Vying Valves: Edwards’ Sapien Progresses, But CoreValve Remains A Threat
This article was originally published in The Gray Sheet
Executive Summary
European data for Edwards Lifesciences' Sapien transcatheter heart valve are encouraging, but analysts have raised questions about design of the firm's planned U.S. trial of the device